Picture of ProstaLund AB logo

PLUN ProstaLund AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: ProstaLund's Method Reduces The Risk Of Developing Prostate Cancer

Jan 11 (Reuters) - ProstaLund AB  PLUND.ST :
    * PROSTALUND'S METHOD REDUCES THE RISK OF DEVELOPING
PROSTATE
CANCER
    * PATIENTS TREATED WITH PROSTALUND'S METHOD, CORETHERM, HAVE
MORE
THAN A HALVED RISK OF GETTING A PROSTATE CANCER DIAGNOSIS

Source text for Eikon:  ID:nMFN1V1Lxg 
Further company coverage:  PLUND.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on ProstaLund AB

See all news